Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis

E-ISSN： 1873-5576|17|6|534-554

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.17, Iss.6, 2017-06, pp. : 534-554

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ciclosporin: Epstein-Barr virus-associated lymphoproliferative disorder: case report

Reactions Weekly, Vol. 1, Iss. 1047, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Recent developments in the prevention and treatment of Epstein–Barr virus-associated lymphoproliferative diseases

By Meerbach Astrid Gruhn Bernd Wutzler Peter

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 4, 2004-04 ,pp. : 527-547

Informa Healthcare

Access to resources Recommend Favorite

Methotrexate: Epstein-Barr virus-associated B-cell lymphoma: case report

Reactions Weekly, Vol. 1, Iss. 1196, 2008-01 ,pp. : 29-30

Adis International

Access to resources Recommend Favorite

Ciclosporin/mycophenolate mofetil/prednisolone: Epstein-Barr virus-associated lymphoma: case report

Reactions Weekly, Vol. 1, Iss. 1202, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Cyclophosphamide/everolimus/fludarabine: Fatal Epstein-Barr virus-associated lymphoproliferative disorder in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1174, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite